A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors

计划入组 258 人 · 首次发布于 2025 年 11 月 17 日

Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom

计划入组 92 人 · 首次发布于 2025 年 11 月 20 日

RPI.4610 in Treating Patients With Metastatic Kidney Cancer

首次发布于 2004 年 2 月 16 日

PBI-4610

RPI-4610

SVR GROUP

France

SPR Therapeutics, Inc.

United States

SHS INTERNATIONAL LIMITED

Hong Kong, China

Hengrui Medicine Gains Clinical Trial Approval for Ten New Drugs, Including Weight Loss

SHR-A1811 Demonstrates Promising Activity in HER2-Expressing Breast Cancer Subtypes

SHR-A1921 Shows Promise in Platinum-Resistant Ovarian Cancer